CLINIQUE MEDFUTURE RECEIVES AN INVESTMENT FROM GNR REVOLUTION
Clinique Medfuture today announces that GNR Revolution is investing in the company to advance its strategic plan.
Mirabel, Quebec, Canada. - Clinique Medfuture today confirms that Genetics Nanotechnology Robotics Revolution inc., a private company, has completed its investment in the company.
Clinique Medfuture positions itself as a pioneer in the field of general services focused on longevity. In addition to at-home blood tests and private laboratory analyses, the company recently launched new genetic tests on the Quebec market to assess biological age as well as a store intended to offer products based on the latest advances in the field of biotechnology in order to slow down aging.
“Several experts believe that within 10 or 15 years, we will add a year to our longevity for every year we live, which will push our life expectancy further into the future.” mentions Mario Tremblay, General Director of Clinique Medfuture. “Medfuture therefore aims to be a facilitator and a support for all those who want to take concrete measures to improve their chances of living longer in health”
The amount of the investment has not been disclosed.
The company plans to expand its range of services and products in the future through virtual medicine, regenerative medicine and anti-aging therapies.
About Clinique Medfuture Inc.
Clinique Medfuture's mission is to improve the longevity of their clients through prevention, the use of cutting-edge technology and the practice of advanced medicine. The company currently offers a home or business blood sampling service, more than 2,000 laboratory tests and analyzes with most results within 24 hours, whether routine tests or more specialized preventive genetic tests, in addition to 'an online store offering anti-aging products.